{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:23Z","timestamp":1791357443479,"version":"4.3.1"},"reference-count":103,"publisher":"Korean College of Neuropsychopharmacology","issue":"2","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.9758\/cpn.2021.19.2.367","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T08:20:10Z","timestamp":1619166010000},"page":"367-387","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["\u2018Z-trip\u2019? A Comprehensive Overview and a Case-series of Zolpidem Misuse"],"prefix":"10.9758","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6882-3770","authenticated-orcid":false,"given":"Laura","family":"Orsolini","sequence":"first","affiliation":[{"name":"Unit of Clinical Psychiatry, Department of Neurosciences\/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy"},{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-1540","authenticated-orcid":false,"given":"Stefania","family":"Chiappini","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-3648","authenticated-orcid":false,"given":"Paolo","family":"Grandinetti","sequence":"additional","affiliation":[{"name":"NHS, Department of Territorial Assistance, Service for Addictions (SerD), Teramo, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-8824","authenticated-orcid":false,"given":"Angelo","family":"Bruschi","sequence":"additional","affiliation":[{"name":"NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Belcolle Hospital, Viterbo, Rome"},{"name":"Catholic University of the Sacred Heart, Rome"},{"name":"Istituto di Psicopatologia, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Testa","sequence":"additional","affiliation":[{"name":"NHS, Department of Mental Health, AUSL Reggio Emilia, Reggio Emilia, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Provenzano","sequence":"additional","affiliation":[{"name":"NHS, Department of Mental Health, ASL Viterbo, Viterbo, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-5058","authenticated-orcid":false,"given":"Domenico De","family":"Berardis","sequence":"additional","affiliation":[{"name":"NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, G. Mazzini Hospital, Teramo, Rome"},{"name":"Department of Neuroscience, Imaging and Clinical Science, G. D\u2019Annunzio University, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9166-7609","authenticated-orcid":false,"given":"Umberto","family":"Volpe","sequence":"additional","affiliation":[{"name":"Unit of Clinical Psychiatry, Department of Neurosciences\/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4713","reference":[{"key":"ref1","unstructured":"National Institute for Health and Care Excellence (NICE). Guidance on the use of zaleplon, zolpidem and zopiclone for the shortterm management of insomnia. London:National Institute for Health and Care Excellence (NICE);2004."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30331-1"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855343"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519010-00008"},{"key":"ref5","unstructured":"Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006;56:964-967."},{"key":"ref6","unstructured":"Barry M. Guidance on appropriate prescribing of benzodiazepines and z-drugs (BZRA) in the treatment of anxiety and insomnia [Internet]. Dublin: Health Service Executive; 2018 Feb [cited at 2019 Oct 14]. Available from: <a target=\"_blank\" href=\"https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/ncps\/medicines-management\/bzra-for-anxiety-insomnia\/bzraguidancemmpfeb18.pdf.\" rel=\"noopener\">https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/ncps\/medicines-management\/bzra-for-anxiety-insomnia\/bzraguidancemmpfeb18.pdf.<\/a>."},{"key":"ref7","unstructured":"Advisory Council on the Misuse of Drugs. Z-drugs: a review of the evidence of misuse and harm [Internet]. London: Advisory Council on the Misuse of Drugs; 2013 Sep 5 [cited at 2019 Oct 15]. Available from: <a target=\"_blank\" href=\"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/237037\/ACMD_advice_Z_drugs.pdf.\" rel=\"noopener\">https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/237037\/ACMD_advice_Z_drugs.pdf.<\/a>."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy264"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X691865"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2018.10.008"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2531-4"},{"key":"ref12","unstructured":"Stahl SM, Grady MM, Muntner N. Stahl's essential psychopharmacology: prescriber's guide antidepressants. 6th ed. Cambridge:Cambridge University Press;2017."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-013-0292-0"},{"key":"ref14","unstructured":"Ford C, Law F. Guidance for the use andreduction of misuse ofbenzodiazepines and otherhypnotics and anxiolytics ingeneral practice [Internet]. Shropshire: SMMGP\/FDAP; 2014 Jul [cited at 2019 Oct 15]. Available from: <a target=\"_blank\" href=\"http:\/\/webcache.googleusercontent.com\/search?q=cache:I4LK1SmkhnYJ:www.emcdda.europa.eu\/attachements.cfm\/att_248926_EN_UK59_benzos.pdf+&cd=11&hl=it&ct=clnk&gl=it\" rel=\"noopener\">http:\/\/webcache.googleusercontent.com\/search?q=cache:I4LK1SmkhnYJ:www.emcdda.europa.eu\/attachements.cfm\/att_248926_EN_UK59_benzos.pdf+&cd=11&hl=it&ct=clnk&gl=it<\/a>."},{"key":"ref15","unstructured":"World Health Organization. WHO Expert Committee on drug dependence [Internet]. Geneva: World Health Organization; 2001 [cited at 2019 Oct 16]. Available from: <a target=\"_blank\" href=\"https:\/\/apps.who.int\/iris\/handle\/10665\/42406\" rel=\"noopener\">https:\/\/apps.who.int\/iris\/handle\/10665\/42406<\/a>."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-3057(98)00102-6"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00491.x"},{"key":"ref18","unstructured":"Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry 2005;66 Suppl 9:31-41."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2014.882725"},{"key":"ref20","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The misuse of benzodiazepines among high-risk opioid users in Europe [Internet]. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2018 [cited at 2019 Oct 15]. Available from: <a target=\"_blank\" href=\"https:\/\/emcdda.europa.eu\/topics\/pods\/benzodiazepines\" rel=\"noopener\">https:\/\/emcdda.europa.eu\/topics\/pods\/benzodiazepines<\/a>."},{"key":"ref21","unstructured":"Erowid. Zolpidem [Internet]. Grass Valley: Erowid; 2019 [cited at 2019 Oct 15]. Available from: <a target=\"_blank\" href=\"https:\/\/erowid.org\/pharms\/zolpidem\/zolpidem.shtml\" rel=\"noopener\">https:\/\/erowid.org\/pharms\/zolpidem\/zolpidem.shtml<\/a>."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1628216"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109643"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030858"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030858"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lin Y, Tang WK, Liang HJ, Tang A, Ungvari GS. Psychiatric morbidity in dependent Z-drugs and benzodiazepine users. Int J Ment Health Addict 2017;15:555-564.","DOI":"10.1007\/s11469-016-9679-x"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Jang Y, Song I, Oh IS, Shin JY. Twelve-year trend in the use of zolpidem and physicians' non-compliance with recommended duration: a Korean national health insurance database study. Eur J Clin Pharmacol 2019;75:109-117.","DOI":"10.1007\/s00228-018-2563-9"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031483"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02861.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149252"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427020-00004"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2015-9"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz007"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Shukla L, Bokka S, Shukla T, Kandasamy A, Chand P, Benegal V, et al. Benzodiazepine and \u201cZ-drug\u201d dependence: data from a tertiary care center. Prim Care Companion CNS Disord 2017;16:19.","DOI":"10.4088\/PCC.16br02025"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027443"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_80_14"},{"key":"ref37","unstructured":"U.S. Food and Drug Administration (FDA). FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines. Updated warnings for eszopiclone, zaleplon and zolpidem [Internet]. U.S. Food and Drug Administration; 2019 Apr 30 [cited at 2019 Oct 17]. Available from: <a target=\"_blank\" href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requires-stronger-warnings-about-rare-serious-incidents-related-certain-prescriptioninsomnia\" rel=\"noopener\">https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requires-stronger-warnings-about-rare-serious-incidents-related-certain-prescriptioninsomnia<\/a>."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2019.17.2.323"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7500"},{"key":"ref40","unstructured":"Eslami-Shahrbabaki M, Barfeh B, Nasirian M. Persistent psychosis after abuse of high dose of zolpidem. Addict Health 2014;6:159-162."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC:American Psychiatric Association;2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2003.10.012"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Monti JM, Spence DW, Buttoo K, Pandi-Perumal SR. Zolpidem's use for insomnia. Asian J Psychiatr 2017;25:79-90.","DOI":"10.1016\/j.ajp.2016.10.006"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91522-n"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1330-a"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.45.1.88"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02473.x"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.117152"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/2008-2231-22-54"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12147"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7240"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3109\/15622970309167957"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.04.018"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000166404.41850.b4"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.11.001"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.09.011"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/136515002761581036"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1080\/10550490600860643"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701641116"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802139168"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017001723"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Ahmadi J. Misuse of zolpidem to get high: a distinguished mystery. Neuropsychiatry (London) 2016;6:64-67.","DOI":"10.4172\/Neuropsychiatry.1000120"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1346084"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12356"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2011.01.023"},{"key":"ref67","unstructured":"Heydari M, Isfeedvajani MS. Zolpidem dependence, abuse and withdrawal: a case report. J Res Med Sci 2013;18:1006-1007."},{"key":"ref68","unstructured":"Mohapatra S, Rath NR, Mental NR. Zolpidem dependence: a case report. East J Psychiatry 2014;17:46-48."},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Sullivan G, McBride AJ, Clee WB. Zopiclone abuse in South Wales: three case reports. Human Psychopharmacol 1995;10:351-352.","DOI":"10.1002\/hup.470100417"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2000.tb00809.x"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015030-00008"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.00273.x"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych11030070"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181d169ed"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-011-0597-y"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.2.114"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91935-2"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92862-n"},{"key":"ref79","unstructured":"Pies RW. Dose-related sensory distortions with zolpidem. J Clin Psychiatry 1995;56:35-36."},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-8343(96)00059-x"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)91561-5"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1038\/nature08758"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2011.04.019"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2010.12.004"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.12.2058-a"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1177\/070674370104600315"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n0801"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31820a3b5a"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D339"},{"key":"ref90","unstructured":"Wang LJ, Ree SC, Chu CL, Juang YY. Zolpidem dependence and withdrawal seizure: report of two cases. Psychiatr Danub 2011;23:76-78."},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.19926"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2011.09.012"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.08.016"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12149"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520220015010"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Chien C, Huanga H, Lung F, Lin C. Zolpidem withdrawal delirium, seizure, and acute psychosis: case reports and literature review. J Subst Use 2011;16:330-338.","DOI":"10.3109\/14659890903013067"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1327609"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Majumder U, Das R, Lenin Singh R. Zolpidem dependence with frontal lobe syndrome: a case report. Int J Basic Clin Pharmacol 2017;6:2936-2938.","DOI":"10.18203\/2319-2003.ijbcp20175222"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.07.009"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.2.306"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03028.x"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200009000-00008"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1177\/026988119801200114"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-02-19.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-02-19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T02:49:20Z","timestamp":1620614960000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5,31]]}},"alternative-id":["10.9758\/cpn.2021.19.2.367"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2021.19.2.367","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"value":"1738-1088","type":"print"},{"value":"2093-4327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.367","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.2.367","name":"the_journal","label":"Clin Psychopharmacol Neurosci","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2020-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"https:\/\/orcid.org\/0000-0002-6882-3770","URL":"https:\/\/orcid.org\/0000-0002-6882-3770","name":"author","label":"Laura Orsolini","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-6810-1540","URL":"https:\/\/orcid.org\/0000-0002-6810-1540","name":"author","label":"Stefania Chiappini","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0003-2015-3648","URL":"https:\/\/orcid.org\/0000-0003-2015-3648","name":"author","label":"Paolo Grandinetti","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-2581-8824","URL":"https:\/\/orcid.org\/0000-0002-2581-8824","name":"author","label":"Angelo Bruschi","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0003-4415-5058","URL":"https:\/\/orcid.org\/0000-0003-4415-5058","name":"author","label":"Domenico De Berardis","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0001-9166-7609","URL":"https:\/\/orcid.org\/0000-0001-9166-7609","name":"author","label":"Umberto Volpe","group":{"name":"orcid","label":"ORCID"}},{"value":"\u00a9 2021 The Korean College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}